Guide to understanding and supporting international medical graduates in hematology/oncology by the ASCO International Medical Graduates Community of Practice Review


Authors: Dizman, N.; Bakouny, Z.; Haykal, T.; Riano, I.; Desai, A.; Butt, A.; Basu, A.; Zhao, D.; Saad, E.; Saliby, R. M.; Gosain, R.; Gosain, R.; Ardeshir, F.; Deng, L.; Matt-Amaral, L.; Arnaoutakis, K.; Bekaii-Saab, T.; Manochakian, R.; Marshall, A.; Forde, P.; Murphy, M.; Subbiah, V.; Chavez-MacGregor, M.; Owonikoko, T. K.; Lopes, G.; Aggarwal, C.; Lee, A. I.; Choueiri, T. K.
Review Title: Guide to understanding and supporting international medical graduates in hematology/oncology by the ASCO International Medical Graduates Community of Practice
Abstract: PURPOSEInternational medical graduates (IMGs) are an essential component of the oncology workforce in the United States, comprising a third of all practicing oncologists and almost half of hematology/oncology fellows. In this article, we discuss the contributions of IMGs in the US oncology workforce, review unique challenges faced by IMGs, and propose potential solutions to overcome these challenges.METHODSASCO's IMG Community of Practice was established with the mission to connect, mentor, guide, raise awareness, and overcome the challenges unique to IMGs interested in pursuing medical oncology in the United States. The content of this article is based on discussions at the IMG Community of Practice meetings at ASCO's 2023 and 2024 Annual Meetings.RESULTSIMGs bring an inherent diversity of thought and experience to the oncology workforce. They provide high-quality, culture- and language-concordant care to a diverse population of patients with cancer. However, IMGs in oncology face significant hardships throughout their careers, including visa-related restrictions, psychosocial and cultural struggles, as well as differential treatment while applying for residency and fellowship training, and early career positions. Greater awareness of these challenges among the members of the hematology/oncology community, along with institutional and individual efforts to support IMGs, is warranted.CONCLUSIONWe encourage oncology professionals and institutions to join our efforts in recognizing the unique paths of IMGs and providing support and advocacy to maximize the potential of IMGs in the US oncology workforce.
Keywords: experiences
Journal Title: JCO Oncology Practice
Volume: 21
Issue: 3
ISSN: 2688-1527
Publisher: American Society of Clinical Oncology  
Date Published: 2025-03-01
Start Page: 292
End Page: 299
Language: English
ACCESSION: WOS:001448421000005
DOI: 10.1200/op-24-00565
PROVIDER: wos
PUBMED: 39374449
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors